1) American Psychiatric Association:Practice guideline for the treatment of patients with delirium. APA, Washington DC, 1999
2) Chochinov HM, Breitbart W:Handbook of Psychiatry in Palliative Medicine. Oxford University Press, New York, 2000(内富庸介 監訳:緩和医療における精神医学ハンドブック.星和書店,2001)
3) Flacker JM, Cummings V, Mach JR Jr, et al:The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry 6:31-41, 1998
4) Kaasinen V, Någren K, Järvenpää T, et al:Regional effects of donepezil and rivastigmine on cortical acetylchoinesterase activity in Alzheimer's disease. J Clin Psychopharmaol 22:615-620, 2002
5) Lipowski ZJ:Delirium:Acute confusional states. Oxford University Press, New York, 1990
6) Liptzin B, Laki A, Garb J, et al:Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry 13:1100-1106, 2005
7) 村岡勲,白木比奈子,鍋島俊隆:アルツハイマー型痴呆の治療薬について.現代医学 48:517-524, 2001
8) 日本総合病院精神医学会薬物療法検討小委員会:せん妄の治療指針.日本総合病院精神医学会治療指針1.星和書店,2005
9) 岡島美朗:せん妄の鑑別診断―うつ病との関係に注目して.精神科治療学 22:985-990, 2007
10) O'keefe ST, Lanvan JN:Clinical signification of delirium subtypes in older people. Age Aging 28:115-119, 1999
11) Wengel SP, Roccaforte WH, Burke WJ:Donepezil improves symptoms of delirium in dementia:Implications for future research. J Geriat Psychiatry Neurol 11:159-161, 1998